Clinical Trials
35 trialsBiomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
GOG Foundation
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Eastern Cooperative Oncology Group
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
SWOG Cancer Research Network
Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab
Eastern Cooperative Oncology Group
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
Eastern Cooperative Oncology Group
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Eastern Cooperative Oncology Group
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Eastern Cooperative Oncology Group
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Eastern Cooperative Oncology Group
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Eastern Cooperative Oncology Group
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Eastern Cooperative Oncology Group
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab
Eastern Cooperative Oncology Group
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
Eastern Cooperative Oncology Group
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Eastern Cooperative Oncology Group
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Eastern Cooperative Oncology Group
Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
Eastern Cooperative Oncology Group
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911
SWOG Cancer Research Network
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Children's Oncology Group
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Children's Oncology Group
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Children's Oncology Group
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
Children's Oncology Group
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
Children's Oncology Group
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
Children's Oncology Group
Protein Expression in Samples From Young Patients With Rhabdomyosarcoma
Children's Oncology Group
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Studying Gene Expression in Samples From Younger Patients With Neuroblastoma
Children's Oncology Group
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Children's Oncology Group
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma
Children's Oncology Group
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
Children's Oncology Group
Biomarkers in Samples From Young Patients With Neuroblastoma
Children's Oncology Group
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
SWOG Cancer Research Network
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial
NSABP Foundation Inc
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313
SWOG Cancer Research Network
SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
SWOG Cancer Research Network
Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100
Eastern Cooperative Oncology Group